title: Early surgery after coronary revascularization: a fine line between bleeding and thrombosis.
abstract: Management of PCI patients undergoing early surgery is still a matter of debate. Noteworthy, PCI patients require a dual antiplatelet therapy (DAPT), with aspirine and a thienopiridine (clopidogrel, prasugrel, ticagrelor), because of the high risk of stent thrombosis (ST), myocardial infarction (MI) and death, especially within the first month. Indeed, the number of surgical interventions after PCI is actually increasing, and physicians are looking for the best antiplatelet therapy management, in order to reduce both, bleeding and thrombosis risk. In this paper, current guidelines therapy management and new optional strategies to reduce the cardiovascular risk, related to early surgery, are discussed.
authors: Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Italy.
authors: C
authors: C
authors: De Biase
authors: Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Italy.
authors: E
authors: E
authors: Capuano
authors: Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Italy.
authors: S
authors: S
authors: De Luca
authors: Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Italy.
authors: C
authors: C
authors: D'Anna
authors: Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Italy.
authors: R
authors: R
authors: Luciano
authors: F
authors: F
authors: Piscione
authors: Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Italy.
authors: B
authors: B
authors: Trimarco
authors: Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Italy.
authors: G
authors: G
authors: Galasso
keywords: antiplatelet therapy; bleeding; non-cardiac surgery; percutaneous coronary intervention; stent thrombosis